Mark Laible
4PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Mar 16, 2026
Evaluating Claudin-6 and isochromosome 12p in the progression from germ cell neoplasia in situ to primary testicular germ cell tumor and post-chemotherapy teratoma: implications for CLDN6-targeted therapies.Ciara Conduit, Bruno Valentin Sinn, Catherine Mitchell
|Mar 28, 2025
The Chimeric Antigen Receptor T Cell Target Claudin 6 Is a Marker for Early Organ-Specific Epithelial Progenitors and Is Expressed in Some Pediatric Solid Tumor Entities.Larissa Seidmann, Arthur Wingerter, Marie Oliver Metzig
|Jul 17, 2019
Impact of molecular subtypes on the prediction of distant recurrence in estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrine therapy.Mark Laible, Kerstin Hartmann, Claudia Gürtler
|Jul 09, 2016
Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens.Mark Laible, Kornelia Schlombs, Katharina Kaiser
Pageof 1
Frequent Collaborators
1 joint publications
Arsenij Ustjanzew
1 joint publications
Claudia Paret
1 joint publications
Jörg Faber
1 joint publications
Ciara Conduit
1 joint publications
Bruno Valentin Sinn
1 joint publications
Catherine Mitchell
1 joint publications
Jonas Leichsenring
1 joint publications
Miku Kuba
1 joint publications
Sophie O'Haire
1 joint publications
Ben Tran
